Product Information

BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Padagis US LLC, priced at $0.0714 per ML under NDC 00574110416. Its NADAC has been published 600 times since Feb 25, 2015.

FDA first approved this application on Jul 15, 2014. Its Orange Book therapeutic-equivalence code is AA.

Strength

2; 10; 30 mg/5mL; mg/5mL; mg/5mL

Manufacturer

Padagis US LLC

NDC

00574110416

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205292

FDA Approved

7/15/2014

TE Code

AA

On Market Since

2/6/2015

Pharmacological Classes

Adrenergic alpha-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 600 times since Feb 25, 2015, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0714 per ML
All-time high$0.1851 (Apr 15, 2015)
All-time low$0.0503 (Aug 17, 2022)
52-week high$0.0876
52-week low$0.0709
Median price$0.0834
Average price$0.0972
Largest weekly change+38.6% (Jul 22, 2020)
Weeks tracked600
Tracking sinceFeb 25, 2015

Price History

1W

-1.7%

1M

-1.7%

3M

-0.8%

6M

-2.4%

1Y

-18.5%

3Y

-8.7%

5Y

+22.4%

All

-61.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Padagis US LLC, is $0.0714 per ML (NDC 00574110416), effective Aug 19, 2026.

How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?

Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has declined 61.1%. It has been tracked across 600 weekly CMS publications since Feb 25, 2015.

What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Since Feb 25, 2015, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0503 (Aug 17, 2022) to a high of $0.1851 (Apr 15, 2015), with a median of $0.0834 per ML.

Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMPHEN-PSE-DM 2-30-10 MG/5 ML in a comparable dosage form, but none are currently priced below it.

Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 00574110416) is labeled by Padagis US LLC, and CMS classifies it as a generic product.